¼¼°èÀÇ ´ã³¶¾Ï Ä¡·áÁ¦ ½ÃÀå(2024-2028³â)
Global Gallbladder Cancer Therapeutics Market 2024-2028
»óǰÄÚµå : 1400440
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 166 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,617,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,787,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°³¿ä

´ã³¶¾Ï Ä¡·áÁ¦ ½ÃÀåÀº 2023-2028³â 1¾ï 4,147¸¸ ´Þ·¯·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 6.63%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­´Â ´ã³¶¾Ï Ä¡·áÁ¦ ½ÃÀå¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ÃËÁø¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. °³¹ßµµ»ó±¹ ½ÃÀåÀÇ ³ôÀº ´ã³¶¾Ï ¹ßº´·ü, ´ã³¶¾ÏÀÇ À§Çè ¿äÀÎ, ´ã³¶¾Ï Ä¡·á¸¦ À§ÇÑ ¸é¿ª¿ä¹ýÀÇ µîÀå µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ 2023
Á¾·á ¿¬µµ 2028
¿¹Ãø ±â°£ 2024-2028
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â ´ëºñ 2024³â 5.42%
CAGR 6.63%
ÁõºÐ ±Ý¾× 1¾ï 4,147¸¸ ´Þ·¯

ÀÌ º¸°í¼­´Â ÇâÈÄ ¸î ³â°£ ´ã³¶¾Ï Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ´ã³¶¾Ï¿¡ ´ëÇÑ °­·ÂÇÑ ÆÄÀÌÇÁ¶óÀÎÀ» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, ¸é¿ª¿ä¹ý ¹× Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) ±â¹Ý °Ë»çÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ö¿ä¸¦ °ßÀÎÇÏ´Â ¿äÀÎÀ¸·Î ²ÅÇû½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå »óȲ

Á¦3Àå ½ÃÀå ±Ô¸ð

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦5Àå Five Forces ºÐ¼®

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Çüº°

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­ : ¿ëµµº°

Á¦8Àå °í°´ »óȲ

Á¦9Àå Áö¿ªº° »óȲ

Á¦10Àå ÃËÁø¿äÀÎ, °úÁ¦ ¹× µ¿Çâ

Á¦11Àå º¥´õ »óȲ

Á¦12Àå º¥´õ ºÐ¼®

Á¦13Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Abstract

The gallbladder cancer therapeutics market is forecasted to grow by USD 141.47 mn during 2023-2028, accelerating at a CAGR of 6.63% during the forecast period. The report on the gallbladder cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the strong incidence of gallbladder cancer in developing countries, risk factors of gallbladder cancer, and the advent of immunotherapy for the treatment of gallbladder cancer.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.42%
CAGR6.63%
Incremental Value$141.47mn

Technavio's gallbladder cancer therapeutics market is segmented as below:

By Type

By Application

By Geography

This study identifies the strong pipeline for gallbladder cancer as one of the prime reasons driving the gallbladder cancer therapeutics market growth during the next few years. Also, the rising adoption of immunotherapy and next-generation sequencing (NGS) based testing will lead to sizable demand in the market.

The report on the gallbladder cancer therapeutics market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gallbladder cancer therapeutics market vendors that include AbbVie Inc., AstraZeneca Plc, B.Braun SE, Boston Scientific Corp., Bristol Myers Squibb Co., Conmed Corp., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Medtronic Plc, Merck KGaA, Novartis AG, Olympus Corp., Pfizer Inc., Sanofi SA, Smith and Nephew plc, and Sun Pharmaceutical Industries Ltd.. Also, the gallbladder cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Market Segmentation by Application

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â